# Lineage Cell Therapeutics, Inc.: Form DEF 14A, filed Apr 29, 2024

- Company: [Lineage Cell Therapeutics, Inc.](/companies/lctx.md) (CIK 876343)
- Form: DEF 14A
- Filed: 2024-04-29
- Accepted by EDGAR: Apr 29, 2024, 16:30 ET
- Period: 2024-06-11
- Accession: 0000950170-24-049935
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/876343/000095017024049935/lctx_proxy_2024.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/876343/000095017024049935/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/876343/000095017024049935/lctx_proxy_2024.htm

Filed Apr 29, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-049935. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.